Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant

Implementation of an Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant: Pilot Feasibility Study

After the initial monitoring period during hospitalization and isolation, patients with recent transplants are regularly monitored in monthly consultations but are still fragile, immunosuppressed and undergoing many treatments. The implementation of an outpatient assistance program for transplant patients should be feasible and allow for the improvement in medical-psycho-social care for the patients during this fragile and risky period, improve the satisfaction and quality of life for these transplant patients and assist in their socio-professional and familial reintegration.

Inclusion Criteria:

• Adult patients over 18 years of age
• Having received an allogeneic hematopoietic stem-cell transplant
• In full remission
• Outpatients
• Having given their informed consent for the participation in the outpatient assistance program with a navigation nurse (AMA-ALLO) at the first post-transplant consultation (starting on Day 100 +/- 10 days post-transplant i.e., when the patient passes the initial post-transplant monitoring period in hospitalization (conventional or by day) to the monitoring period in monthly medical consultations) and continuing for 12 months
• Affiliated with the social security system

Exclusion Criteria:

• Transplant patients not having given their informed consent for inclusion in AMA-ALLO
• Hospitalized or non-outpatient transplant patients
• Post-transplant patients in cytological relapse
• Patients under a legal regime of adult protection (guardianship, curatorship, etc.)